Kurs & Likviditet
Prenumeration
Kalender
2025-02-13 | Bokslutskommuniké 2024 |
2024-10-24 | Kvartalsrapport 2024-Q3 |
2024-07-18 | Kvartalsrapport 2024-Q2 |
2024-05-10 | Ordinarie utdelning STIL 0.00 SEK |
2024-05-08 | Årsstämma 2024 |
2024-04-25 | Kvartalsrapport 2024-Q1 |
2024-02-16 | Bokslutskommuniké 2023 |
2023-12-29 | Extra Bolagsstämma 2023 |
2023-10-26 | Kvartalsrapport 2023-Q3 |
2023-07-14 | Kvartalsrapport 2023-Q2 |
2023-05-08 | Ordinarie utdelning STIL 1.80 SEK |
2023-05-05 | Årsstämma 2023 |
2023-04-27 | Kvartalsrapport 2023-Q1 |
2023-02-17 | Bokslutskommuniké 2022 |
2022-10-27 | Kvartalsrapport 2022-Q3 |
2022-07-15 | Kvartalsrapport 2022-Q2 |
2022-05-06 | Ordinarie utdelning STIL 1.00 SEK |
2022-05-05 | Årsstämma 2022 |
2022-05-01 | Kvartalsrapport 2022-Q1 |
2022-02-17 | Bokslutskommuniké 2021 |
2021-10-27 | Kvartalsrapport 2021-Q3 |
2021-07-16 | Kvartalsrapport 2021-Q2 |
2021-05-05 | Ordinarie utdelning STIL 1.70 SEK |
2021-05-04 | Årsstämma 2021 |
2021-04-28 | Kvartalsrapport 2021-Q1 |
2021-02-18 | Bokslutskommuniké 2020 |
2020-10-29 | Kvartalsrapport 2020-Q3 |
2020-08-20 | Kvartalsrapport 2020-Q2 |
2020-05-28 | Ordinarie utdelning STIL 0.00 SEK |
2020-05-27 | Årsstämma 2020 |
2020-04-29 | Kvartalsrapport 2020-Q1 |
2020-02-20 | Bokslutskommuniké 2019 |
2019-10-31 | Kvartalsrapport 2019-Q3 |
2019-08-22 | Kvartalsrapport 2019-Q2 |
2019-05-03 | Ordinarie utdelning STIL 1.45 SEK |
2019-05-02 | Årsstämma 2019 |
2019-05-02 | Kvartalsrapport 2019-Q1 |
2019-02-25 | Bokslutskommuniké 2018 |
2018-11-22 | Kvartalsrapport 2018-Q3 |
2018-08-23 | Kvartalsrapport 2018-Q2 |
2018-05-17 | Kvartalsrapport 2018-Q1 |
2018-04-23 | Ordinarie utdelning STIL 1.20 SEK |
2018-04-20 | Årsstämma 2018 |
2018-02-22 | Bokslutskommuniké 2017 |
2017-11-16 | Kvartalsrapport 2017-Q3 |
2017-08-24 | Kvartalsrapport 2017-Q2 |
2017-05-18 | Kvartalsrapport 2017-Q1 |
2017-04-27 | Ordinarie utdelning STIL 1.00 SEK |
2017-04-26 | Årsstämma 2017 |
2017-02-16 | Bokslutskommuniké 2016 |
2016-11-17 | Kvartalsrapport 2016-Q3 |
2016-08-25 | Kvartalsrapport 2016-Q2 |
2016-05-19 | Kvartalsrapport 2016-Q1 |
2016-04-29 | Ordinarie utdelning STIL 0.80 SEK |
2016-04-28 | Årsstämma 2016 |
2016-02-18 | Bokslutskommuniké 2015 |
2015-11-17 | Kvartalsrapport 2015-Q3 |
2015-08-25 | Kvartalsrapport 2015-Q2 |
2015-05-19 | Kvartalsrapport 2015-Q1 |
2015-04-16 | Ordinarie utdelning STIL 0.00 SEK |
2015-04-15 | Årsstämma 2015 |
2015-02-18 | Bokslutskommuniké 2014 |
2014-11-19 | Kvartalsrapport 2014-Q3 |
2014-08-28 | Kvartalsrapport 2014-Q2 |
2014-07-30 | Ordinarie utdelning STIL 1.00 SEK |
2014-05-14 | Kvartalsrapport 2014-Q1 |
2014-04-03 | Årsstämma 2014 |
2014-02-20 | Bokslutskommuniké 2013 |
2013-11-28 | Kvartalsrapport 2013-Q3 |
2013-08-29 | Kvartalsrapport 2013-Q2 |
2013-05-28 | Kvartalsrapport 2013-Q1 |
2013-04-26 | Ordinarie utdelning STIL 0.00 SEK |
2013-04-25 | Årsstämma 2013 |
2013-02-20 | Bokslutskommuniké 2012 |
2012-11-20 | Kvartalsrapport 2012-Q3 |
2012-08-29 | Kvartalsrapport 2012-Q2 |
2012-05-16 | Kvartalsrapport 2012-Q1 |
2012-04-19 | Ordinarie utdelning STIL 0.00 SEK |
2012-04-18 | Årsstämma 2012 |
2012-02-15 | Bokslutskommuniké 2011 |
2011-11-16 | Kvartalsrapport 2011-Q3 |
2011-08-24 | Kvartalsrapport 2011-Q2 |
2011-05-18 | Kvartalsrapport 2011-Q1 |
2011-04-14 | Ordinarie utdelning STIL 0.00 SEK |
2011-04-13 | Årsstämma 2011 |
2011-02-16 | Bokslutskommuniké 2010 |
2010-11-24 | Kvartalsrapport 2010-Q3 |
2010-08-18 | Kvartalsrapport 2010-Q2 |
2010-04-16 | Ordinarie utdelning STIL 0.00 SEK |
2010-04-15 | Kvartalsrapport 2010-Q1 |
2010-02-19 | Bokslutskommuniké 2009 |
2009-11-20 | Kvartalsrapport 2009-Q3 |
2009-08-27 | Kvartalsrapport 2009-Q2 |
2009-05-15 | Ordinarie utdelning STIL 0.00 SEK |
2009-05-14 | Kvartalsrapport 2009-Q1 |
2009-04-15 | Årsstämma 1 |
2008-06-24 | Split STIL 100:1 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Stille AB (publ) has successfully completed the previously announced acquisition of the German instrument provider Fehling (Fehling Instruments GmbH & Co. KG, Fehling Verwaltungs GmbH, and associated subsidiaries, collectively referred to as "Fehling"). All conditions for the transaction and acquisition have now been met. As previously communicated, Stille has paid 36 million euros in cash upon the completion of the acquisition on a debt-free and cash-free basis. The acquisition is financed through the previously announced targeted issuance of SEK 425 million.
Fehling develops and sells high-quality medical instruments, focusing on demanding specialties such as open and minimally invasive cardiac, thoracic, neuro, and spine surgery. Fehling has a global sales presence through a combination of direct sales and distributors. Through the acquisition, Stille significantly expands its product range, research and development capacity, and global presence.
Torshälla, January 25th, 2024.
For more information, please contact:
Torbjörn Sköld
CEO and President
+46 (0)70 316 63 91 | torbjorn.skold@stille.se
Stille AB (publ) publ) develops, manufactures and markets medical devices for surgeons across the world. Stille was founded in 1841 and is one of the world’s oldest medical device companies. Stille’s main business areas are surgical instruments and c-arm tables. Stille’s surgical instruments are mostly used during different kinds of open surgery. During minimal invasive procedures. the c-arm tables imagiQ2 and Medstone are key products. The company has a strong brand and products of a renowned high-quality. The share is listed on First North Growth Market under the acronym “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, + 46 8 684 211 10, adviser@eminova.se. For more information, visit www.stille.se.